ask="N/A"
ask_size="N/A"
average_daily_volume="38342"
bid="N/A"
bid_size="N/A"
book_value="-0.94"
change="-0.47"
change_from_200_day_moving_average="-0.36"
change_from_50_day_moving_average="0.14"
change_from_52_week_high="-2.21"
change_From_52_week_low="1.48"
change_in_percent="-12.53%"
close="3.28"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.26"
ebitda="-50.77M"
eps_estimate_current_year="-1.26"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.48"
ex_dividend_date="N/A"
float_shares="12119000"
high="3.77"
high_52_weeks="5.49"
last_trade_date="2/16/2017"
last_trade_price="3.28"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.28"
low_52_weeks="1.80"
market_capitalization="76.08M"
moving_average_200_day="3.64"
moving_average_50_day="3.14"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="3.77"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-10.00%"
percent_change_from_50_day_moving_average="+4.37%"
percent_change_from_52_week_high="-40.26%"
percent_change_from_52_week_low="+81.82%"
previous_close="3.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="38.02"
revenue="2.29M"
shares_outstanding="23196000"
short_ratio="1.11"
stock_exchange="NGM"
symbol="ONS"
volume="134921"
weeks_range_52="1.80 - 5.49"
